Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma Out-licensing: 2012’s “In” Thing?

Jan 24 2012

Related Content

Clovis Oncology Seeks $149.5 Million IPO

Jun 23 2011

Related Companies

Pfizer Inc.

GSK plc

Autifony Therapeutics Limited

Convergence Pharmaceuticals Ltd

Amgen, Inc.

Biogen, Inc.

Merck & Co., Inc.

Clovis Oncology, Inc.

Puma Biotechnology, Inc.

AstraZeneca PLC

MedImmune LLC

Eli Lilly and Company

Additional Topics

Deals BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window